Long-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial

A prespecified subgroup analysis of a 44-week open-label extension study is presented. The efficacy and safety of the combination of amlodipine (AML)+ olmesartan medoxomil (OM), with and without the addition of hydrochlorothiazide (HCTZ), were investigated in patients aged ⩾65 and <65 years, Blac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Oparil, S, Chrysant, S G, Melino, M, Lee, J, Karki, S, Heyrman, R
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2010
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2990108/
https://ncbi.nlm.nih.gov/pubmed/20200547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jhh.2010.16
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares